Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Overview of the IMPACT Analysis Pipeline

Published byRudolf Ross Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1 Overview of the IMPACT Analysis Pipeline"— Presentation transcript:

1 Figure 1 Overview of the IMPACT Analysis Pipeline
From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

2 Figure 2 Prediction algorithms on the deleterious variants
From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

3 Figure 6 Validation of the BRAF, NRAS, and CDKN2A mutations
Figure 6 Validation of the BRAF, NRAS, and CDKN2A mutations. (A) By using qBiomarker Melanoma Somatic Mutation PCR array, we validated BRAF p.V600E is identified in the pre-treatment sample. NRAS p.Q61K was not detected and CDKN2A was detected in the pre-treatment sample. (B) In post-BRAFi/MEKi treatment, BRAF p.V600E and NRAS p.Q61K were detected, and CDKN2A was not detected. This confirms the IMPACT variants and copy number detection in these 3 genes. From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

4 Figure 5 IMPACT tumor heterogeneity and clonal dynamic analyses
Figure 5 IMPACT tumor heterogeneity and clonal dynamic analyses. (A) In the melanoma patient, allele frequency changes for BRAF (p.V600E) and NRAS (p.Q61K), and CDKN2A gene copy number changes between the 3 time points. (B) Allele frequency distributions of somatic mutations in pre-treatment, post-BRAFi-treatment, and post-BRAFi/MEKi treatment in the melanoma patient From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

5 Figure 3 Venn diagram of the somatic variants identified by IMPACT in the 3 melanoma samples
From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

6 Figure 4 CDKN2A loss detection in the melanoma samples
From: IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples J Am Med Inform Assoc. 2016;23(4): doi: /jamia/ocw022 J Am Med Inform Assoc | © The Author Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please

Download ppt "Figure 1 Overview of the IMPACT Analysis Pipeline"

Similar presentations

Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Follicular Variant of Papillary Thyroid Cancer: Encapsulated,

Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Follicular Variant of Papillary Thyroid Cancer: Encapsulated,
From: An open day in the metric space

From: An open day in the metric space
Figure 2: Algorithm for detecting early warning signal of a critical transition. From: Detecting tissue-specific early warning signals for complex diseases.

Figure 2: Algorithm for detecting early warning signal of a critical transition. From: Detecting tissue-specific early warning signals for complex diseases.
Figure 1 The spatial and temporal distribution of diarrhoea rates

Figure 1 The spatial and temporal distribution of diarrhoea rates
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Figure 2. Quality of life (QOL) scores for functional scale items

Figure 2. Quality of life (QOL) scores for functional scale items
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.

Figure 1. FinHER dataset: distribution of tumor-infiltrating lymphocytes in breast cancer according to the (A) three breast cancer subtypes and (B) HER2.
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Figure 1. Period–cohort diagram.

Figure 1. Period–cohort diagram.
Figure 2. Chronic kidney disease risk tool application.

Figure 2. Chronic kidney disease risk tool application.
Source:Ellerman, Convery, and de Perthuis (2010). Figure 6. 2, p

Source:Ellerman, Convery, and de Perthuis (2010). Figure 6. 2, p
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 1 A decision tree diagram for problems and its German correspondences From: Corresponding lexical domains: A new resource for onomasiological.

Figure 1 A decision tree diagram for problems and its German correspondences From: Corresponding lexical domains: A new resource for onomasiological.
Figure 1. Logos appearing in the choice experiment

Figure 1. Logos appearing in the choice experiment
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. VoC conceptual framework linking employment mobility and welfare production regimes From: Complexity in Employment Life Courses in Europe in.

Figure 1. VoC conceptual framework linking employment mobility and welfare production regimes From: Complexity in Employment Life Courses in Europe in.
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Similar presentations

Ads by Google